Skip navigation

Enhance Patient-Centric Services, Optimize Program Effectiveness and Drive Speed to Therapy

September 26-27, 2019
  • San Diego, CA

With mounting cost pressures and increased demands for affordable, value-based treatment options, bio/pharmaceutical teams face an increasingly competitive market, for both specialty and non-specialty products. Increasingly, industry must strategize to manage the most critical challenges associated with product and patient services. CBI’s 13th Hub and SPP Model Optimization provides executives with strategies for developing and integrating hub programs and other patient-centric services to ensure product access and maximize reimbursement.

NEW FEATURES for 2019!

  • 90-minute Patient Experience Panel — Hear critical insights into how to ensure a positive patient journey from start to finish
  • Exclusive, Manufacturer-Only Round Up —
    Knowledge-exchange session to connect on key challenges facing the market access/patient access/channel professionals working within the life sciences industry
  • 2 Patient Spotlights —

    Daiva Debra Minter
    Patient Perspective

    Neil Ross
    National Vice President,
    Business Development & Patient Services
    KabaFusion

  • Panel Session — Fostering a Collaborative Relationship between Manufacturers, SP’s & Hubs

Hear Expert Insights from a Leading Multi-Stakeholder Speaking Faculty on Critical Topics Below:

  • Current litigation/court rulings that impact Hub and SP Models
  • Impact of Medicare Part D and Part B changes to
    Hub and SP Models
  • Copay Accumulator landscape
  • Integration of medical and pharmacy benefits
  • Patient service and support programs to help drive patient adherence and better outcomes
  • Examining EHR data to generate claims data and understand care episodes to see the effectiveness of a therapy
  • Best practices for combining data sources to provide a complete picture of the patient journey
  • Latest trends in cell and gene therapy
  • Tips to prepare for the hubs of the future and designing patient-centric hub models
  • And more!

INDUSTRY ACCLAIM:

CBI’s conferences continue to stay relevant and up to date on industry topics. They also do a good job of bringing in a multi-faceted group of individuals to present and attend with.
I encourage anyone interested in evaluating their perspectives, staying current in an evolving industry, and connecting with others interested in cultivating change to attend this CBI event.

Director, Industry Relations & Market Access, Optimed Health Partners

I attend a lot of industry conferences and CBI consistently has some of the best and most informative conferences that address the current topics I am most interested in learning about.

Executive Director, Managed Markets, Aralez Pharmaceuticals

Very beneficial conference in a dynamic market. Excellent speakers, excellent content and great venue.

Vice President, Portfolio Management, Upsher-Smith

Relatively new to the Hub & SPP World so I found the
content to be informative and useful in gaining a deeper understanding of the challenges that Hubs & SPPs face
when attempting to improve patient care.

Vice President, Sales, Dohmen Life Sciences

13th Hub and SPP Model Optimization

Enhance Patient-Centric Services, Optimize Program Effectiveness and Drive Speed to Therapy

With mounting cost pressures and increased demands for affordable, value-based treatment options, bio/pharmaceutical teams face an increasingly competitive market, for both specialty and non-specialty products. Increasingly, industry must strategize to manage the most critical challenges associated with product and patient services. CBI’s 13th Hub and SPP Model Optimization provides executives with strategies for developing and integrating hub programs and other patient-centric services to ensure product access and maximize reimbursement.

NEW FEATURES for 2019!

  • 90-minute Patient Experience Panel — Hear critical insights into how to ensure a positive patient journey from start to finish
  • Exclusive, Manufacturer-Only Round Up —
    Knowledge-exchange session to connect on key challenges facing the market access/patient access/channel professionals working within the life sciences industry
  • 2 Patient Spotlights —

    Daiva Debra Minter
    Patient Perspective

    Neil Ross
    National Vice President,
    Business Development & Patient Services
    KabaFusion

  • Panel Session — Fostering a Collaborative Relationship between Manufacturers, SP’s & Hubs

Hear Expert Insights from a Leading Multi-Stakeholder Speaking Faculty on Critical Topics Below:

  • Current litigation/court rulings that impact Hub and SP Models
  • Impact of Medicare Part D and Part B changes to
    Hub and SP Models
  • Copay Accumulator landscape
  • Integration of medical and pharmacy benefits
  • Patient service and support programs to help drive patient adherence and better outcomes
  • Examining EHR data to generate claims data and understand care episodes to see the effectiveness of a therapy
  • Best practices for combining data sources to provide a complete picture of the patient journey
  • Latest trends in cell and gene therapy
  • Tips to prepare for the hubs of the future and designing patient-centric hub models
  • And more!

INDUSTRY ACCLAIM:

CBI’s conferences continue to stay relevant and up to date on industry topics. They also do a good job of bringing in a multi-faceted group of individuals to present and attend with.
I encourage anyone interested in evaluating their perspectives, staying current in an evolving industry, and connecting with others interested in cultivating change to attend this CBI event.

Director, Industry Relations & Market Access, Optimed Health Partners

I attend a lot of industry conferences and CBI consistently has some of the best and most informative conferences that address the current topics I am most interested in learning about.

Executive Director, Managed Markets, Aralez Pharmaceuticals

Very beneficial conference in a dynamic market. Excellent speakers, excellent content and great venue.

Vice President, Portfolio Management, Upsher-Smith

Relatively new to the Hub & SPP World so I found the
content to be informative and useful in gaining a deeper understanding of the challenges that Hubs & SPPs face
when attempting to improve patient care.

Vice President, Sales, Dohmen Life Sciences